Filters close

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 26-Jun-2023 5:00 PM EDT Released to reporters: 20-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 26-Jun-2023 5:00 PM EDT Released to reporters: 20-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 23-Jun-2023 12:55 PM EDT
BP Below 120 Could Be Target to Prevent Common Heart Condition
University of California, San Francisco (UCSF)

UCSF researchers have found that aggressive blood pressure control can lower the risk of left ventricular conduction disease, a common heart condition that often leads to pacemaker implantation.

Newswise: Novel way to manipulate exotic materials
Released: 20-Jun-2023 2:05 PM EDT
Novel way to manipulate exotic materials
Oak Ridge National Laboratory

An advance in a topological insulator material — whose interior behaves like an electrical insulator but whose surface behaves like a conductor — could revolutionize the fields of next-generation electronics and quantum computing, according to scientists at Oak Ridge National Laboratory.

Released: 20-Jun-2023 10:05 AM EDT
Wistar Institute Study Gives New Insight into How Cancer Metastasizes to the Brain 
Wistar Institute

PHILADELPHIA — (June 20, 2023) — When cancer that starts in the body metastasizes to the brain, it is almost always lethal, in part because so few treatment options exist. Now a new study by Wistar scientists published in Nature Communications shows that a type of brain cell called astrocytes plays an important role in promoting brain metastasis by recruiting a specific subpopulation of immune cells.

Not for public release

This news release is embargoed until 12-Jun-2023 5:00 PM EDT Released to reporters: 6-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 12-Jun-2023 5:00 PM EDT Released to reporters: 6-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Liver lobe-specific hydrodynamic gene delivery to baboons: A preclinical trial for hemophilia gene therapy
Released: 8-Jun-2023 1:20 PM EDT
Liver lobe-specific hydrodynamic gene delivery to baboons: A preclinical trial for hemophilia gene therapy
Niigata University

The research group of Professor Kamimura in Niigata University have applied the novel, liver lobe-specific hydrodynamic delivery procedure to primates (baboons) for the first time.

   
Newswise: Turning up the heat
Released: 6-Jun-2023 12:05 PM EDT
Turning up the heat
Oak Ridge National Laboratory

Oak Ridge National Laboratory scientists found that a small tweak created big performance improvements in a type of solid-state battery, a technology considered vital to broader electric vehicle adoption.



close
0.24591